Bellamy N - Search Results

1

Variability of skin scores and clinical measurements in scleroderma.

Pope JE, Baron M, Bellamy N, Campbell J, Carette S, Chalmers I, Dales P, Hanly J, Kaminska EA, Lee P, et al. Pope JE, et al. Among authors: bellamy n. J Rheumatol. 1995 Jul;22(7):1271-6. J Rheumatol. 1995. PMID: 7562757 Clinical Trial.

2

Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials.

Pope JE, Bellamy N. Pope JE, et al. Among authors: bellamy n. Clin Invest Med. 1995 Feb;18(1):1-10. Clin Invest Med. 1995. PMID: 7768060

3

A Canadian survey of current methotrexate prescribing practices in rheumatoid arthritis.

Collins D, Bellamy N, Campbell J. Collins D, et al. Among authors: bellamy n. J Rheumatol. 1994 Jul;21(7):1220-3. J Rheumatol. 1994. PMID: 7966061

4

Outcome measurement in scleroderma clinical trials.

Pope JE, Bellamy N. Pope JE, et al. Among authors: bellamy n. Semin Arthritis Rheum. 1993 Aug;23(1):22-33. doi: 10.1016/s0049-0172(05)80024-1. Semin Arthritis Rheum. 1993. PMID: 8235663 Review.

5

Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada.

Bellamy N, Kaloni S, Pope J, Coulter K, Campbell J. Bellamy N, et al. J Rheumatol. 1998 May;25(5):852-8. J Rheumatol. 1998. PMID: 9598879

6

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.

Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE. Pope JE, et al. Among authors: bellamy n. Arthritis Rheum. 2001 Jun;44(6):1351-8. doi: 10.1002/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I. Arthritis Rheum. 2001. PMID: 11407694 Free article. Clinical Trial.

7

Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1992 Mar;19(3):436-43. J Rheumatol. 1992. PMID: 1578460

8

Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.

Bellamy N, Carette S, Ford PM, Kean WF, le Riche NG, Lussier A, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1992 Mar;19(3):444-50. J Rheumatol. 1992. PMID: 1578461

9

Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.

Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Dec;18(12):1893-900. J Rheumatol. 1991. PMID: 1795329

10

Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.

Bellamy N, Anastassiades TP, Buchanan WW, Davis P, Lee P, McCain GA, Wells GA, Campbell J. Bellamy N, et al. J Rheumatol. 1991 Dec;18(12):1901-7. J Rheumatol. 1991. PMID: 1822109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters